Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Inventory is also known as Days Sales of Inventory (DSI). Almirall's Average Total Inventories for the
three
months ended in Jun. 2026 was €175 Mil. Almirall's Cost of Goods Sold for the
three
months ended in Jun. 2026 was €-264 Mil.
The historical rank and industry rank for Almirall's Days Inventory or its related term are showing as below:
XMAD:ALM'
s Days Inventory Range Over the Past 10 Years
Min: 183.42 Med: 237.17 Max: 515.51
Current: 515.51
During the past 13 years, Almirall's highest Days Inventory was 515.51. The lowest was 183.42. And the median was 237.17.
XMAD:ALM's Days Inventory is ranked worse than 95.34% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.72
vs XMAD:ALM: 515.51
Almirall's Days Inventory
declined
from Jun. 2025 (670.48) to Jun. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Almirall's Inventory Turnover for the
three
months ended in Jun. 2026 was -1.51.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Almirall's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.56.
Almirall (XMAD:ALM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Almirall's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Almirall's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Almirall Days Inventory Related Terms
Almirall Days Inventory Historical Data
* Premium members only.
The historical data trend for Almirall's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:ALM vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almirall Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Almirall's Days Inventory distribution charts can be found below:
* The bar in red indicates where Almirall's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almirall (XMAD:ALM) has a Days Inventory of 0.00 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Almirall and its competitors. Over the past decade, Almirall's Days Inventory has ranged from 183.42 to 515.51. According to the industry distribution chart, Almirall ranks #879 out of 922 companies in the Drug Manufacturers industry, placing it in the top 95.3%.
Is Almirall's Days Inventory too high?
Almirall's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 183.42 to a high of 515.51. Based on the distribution chart, Almirall ranks #879 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Almirall has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Almirall's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Almirall ranks #879 out of 922 companies for Days Inventory. This places Almirall in the lower half of its industry. The industry median Days Inventory is 164.72. Historically, Almirall's own Days Inventory has ranged from 183.42 to 515.51 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.72, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Almirall and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almirall's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Based on GuruFocus' analysis, Almirall (XMAD:ALM) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.86, compared to a current price of €11.46 — trading 10.9% below its estimated fair value. The current Days Inventory is 0.00. Almirall's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Almirall (XMAD:ALM), the current Days Inventory is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Almirall (XMAD:ALM) Overvalued in 2026?
Based on GuruFocus' analysis, Almirall stock appears to be undervalued.
The current stock price of €11.46 is trading 10.9% below its estimated GF Value™ of €12.86.
GuruFocus considers Almirall to be Modestly Undervalued.
Key valuation signals for XMAD:ALM:
Days Inventory: 0.00
GF Value™: €12.86 vs. price of €11.46 (10.9% below fair value)
No single metric tells the full story. See the XMAD:ALM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
86GF Score
Get the complete analysis for XMAD:ALM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:ALM has been successfully added to your 
